Bruce Jackson

Stock Analyst at Benchmark

(1.16)
# 1,553
Out of 4,650 analysts
109
Total ratings
30.97%
Success rate
-15.8%
Average return

Stocks Rated by Bruce Jackson

Hoth Therapeutics
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.98
Upside: +207.57%
Milestone Scientific
Oct 10, 2024
Initiates: Speculative Buy
Price Target: $1.25
Current: $0.79
Upside: +57.43%
Humacyte
Oct 10, 2024
Reiterates: Buy
Price Target: $15
Current: $5.32
Upside: +181.95%
CytoMed Therapeutics
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.34
Upside: +113.68%
NeoGenomics
Sep 24, 2024
Reiterates: Buy
Price Target: $18
Current: $13.52
Upside: +33.14%
Unicycive Therapeutics
Sep 6, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.48
Upside: +522.54%
Movano
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $4.42
Upside: -54.75%
Cardio Diagnostics Holdings
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $0.26
Upside: +671.60%
Reviva Pharmaceuticals Holdings
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $1.18
Upside: +1,340.68%
VolitionRx
Aug 16, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.60
Upside: -
Reiterates: Buy
Price Target: $7
Current: $0.88
Upside: +699.09%
Reiterates: Speculative Buy
Price Target: $24
Current: $3.49
Upside: +587.68%
Reiterates: Buy
Price Target: $57
Current: $69.78
Upside: -18.31%
Maintains: Buy
Price Target: $91$67
Current: $69.64
Upside: -3.79%
Reiterates: Speculative Buy
Price Target: $25
Current: $3.09
Upside: +709.06%
Reiterates: Speculative Buy
Price Target: $1
Current: $0.21
Upside: +376.19%
Reiterates: Buy
Price Target: $100
Current: $6.38
Upside: +1,467.40%
Reiterates: Speculative Buy
Price Target: $5
Current: $3.10
Upside: +61.29%
Reiterates: Speculative Buy
Price Target: $5
Current: $2.25
Upside: +122.22%
Downgrades: Hold
Price Target: n/a
Current: $1.79
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $30.29
Upside: -
Reiterates: Speculative Buy
Price Target: $7
Current: $2.45
Upside: +185.71%
Initiates: Speculative Buy
Price Target: $800
Current: $2.99
Upside: +26,655.85%